Estramustine

Estramustine

SCHEMBL7621246

C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O.[NaH].[NaH]

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.98
BLM P54132 2/20 0.98
ESR1 P03372 6/20 0.75
ADORA3 P0DMS8 3/20 0.75
INPPL1 O15357 1/20 0.75
PTPN1 P18031 1/20 0.75
DRD1 P21728 1/20 0.75
PTPN6 P29350 1/20 0.75
KDR P35968 1/20 0.75
PTPN11 Q06124 1/20 0.75
LMNA P02545 5/20 0.72
SMN1; SMN2 Q16637 3/20 0.72
ATM Q13315 2/20 0.72
PGR P06401 2/20 0.72
AR P10275 2/20 0.72
SLC6A3 Q01959 2/20 0.72
CHRM1 P11229 1/20 0.72
TBXA2R P21731 1/20 0.72
ADRA1A P35348 1/20 0.72
OPRM1 P35372 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Estramustine SCHEMBL679202 1.00 RECQL (0.98) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL13753350 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL29374661 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL2348477 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL4252 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL29349776 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL8173336 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL7200287 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL6353316 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1
Estramustine SCHEMBL14031683 0.99 RECQL (1.00) RECQLBLMESR1ADORA3INPPL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130096067-A1 DROSOPHILA TUMOR STEM CELL MODEL AND USES THEREOF PERRIMON NORBERT (US) 2013-04-18 US disclosed
EP-0730474-B1 ESTRAMUSTINE FORMULATIONS WITH IMPROVED PHARMACEUTICAL PROPERTIES PHARMACIA & UPJOHN AB (SE) 2002-06-19 EP disclosed
US-5712260-A WITH CYCLODEXTRIN, IMPROVED BIOAVAILABILITY, ADMINISTERING BY MOUTH, ADVANCED TUMOR TREATMENT PHARMACIA AB (SE) 1998-01-27 US disclosed
EP-0730474-A1 ESTRAMUSTINE FORMULATIONS WITH IMPROVED PHARMACEUTICAL PROPERTIES Pharmacia AB (SE) 1996-09-11 EP disclosed
WO-1996009072-A1 ESTRAMUSTINE FORMULATIONS WITH IMPROVED PHARMACEUTICAL PROPERTIES PHARMACIA AB (SE) 1996-03-28 WO disclosed